(21718246), M. A., (17098997), G. V., (14962659), C. d. A., (15050228), A. V., (14936295), M. P., (21718249), V. A., . . . (14962701), I. M. (2025). Figure 2 from A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer – The MONEO Study.
Chicago-viite (17. p.)(21718246), Maria Alsina, et al. Figure 2 from A Phase II Study of Perioperative Avelumab Plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer – The MONEO Study. 2025.
MLA-viite (9. p.)(21718246), Maria Alsina, et al. Figure 2 from A Phase II Study of Perioperative Avelumab Plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer – The MONEO Study. 2025.